Disruption in supply of diabetes drug Ozempic also in Slovenia

Ljubljana, 2 September - Due to the high demand for the antidiabetic medication Ozempic there are certain disruptions in its supply in Slovenia, with the relevant authorities assuring the public that they are working on alleviating the issue. They have advised against online purchase and noted that the medication is not been approved for weight loss for aesthetic purposes.

The rest of this news item is available to subscribers.
The news item consists of 1.645 characters (without spaces) or 314 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

zm/ep
© STA, 2024